Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shenzhen Stock Exchange
  5. Shenzhen Salubris Pharmaceuticals Co., Ltd.
  6. News
  7. All News
    002294   CNE100000FW8

SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.

(002294)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
All news about SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.
10/25Shenzhen Salubris Pharmaceuticals Co., Ltd. Reports Earnings Results for the Nine Month..
CI
10/07Tranche Update on Shenzhen Salubris Pharmaceuticals Co., Ltd.'s Equity Buyback Plan ann..
CI
09/05Shenzhen Salubris Pharmaceuticals Co., Ltd. announces an Increase in Equity Buyback.
CI
08/23Viracta Up 5% After It Reacquires Rights to Combination Therapy in China
DJ
08/23VIRACTA THERAPEUTICS : Reacquires Exclusive Rights to Combination Therapy Candidate for Ly..
MT
08/23Shenzhen Salubris Pharmaceuticals Co., Ltd. Reports Earnings Results for the Half Year ..
CI
08/06SKILLFUL CRAFTSMAN EDUCATION TECHNOL : Names Dawei Chen as Chief Financial Officer
MT
07/25Shenzhen Salubris Pharmaceuticals Co., Ltd. announces an Equity Buyback for CNY 200 mil..
CI
07/25Shenzhen Salubris Pharmaceuticals Co., Ltd. authorizes a Buyback Plan.
CI
07/25SHENZHEN SALUBRIS PHARMACEUTICALS CO : 002294) intends to launch an Equity Buyback Plan.
CI
07/02Salubris Biotechnology Co., Ltd. announced that it expects to receive CNY 263.8 million..
CI
06/22Shenzhen Salubris Pharmaceuticals Co., Ltd. announced that it has received CNY 1.951871..
CI
06/14ROSY METRO LIMITED acquired a 13.78% stake in M.A. Med Alliance S.A from Shenzhen Salub..
CI
04/19Shenzhen Salubris Pharmaceuticals Co., Ltd. Reports Earnings Results for the First Quar..
CI
03/30NORTAI International Ltd. announced that it expects to receive $80 million in funding f..
CI
03/29Shenzhen Salubris Pharmaceuticals Co., Ltd. Reports Earnings Results for the Full Year ..
CI
2020Shenzhen Salubris Biomedical Engineering Co., Ltd. announced that it has received CNY 3..
CI
2020Tranche Update on Shenzhen Salubris Pharmaceuticals Co., Ltd.'s Equity Buyback Plan ann..
CI
2020Shenzhen Salubris Biomedical Engineering Co., Ltd. announced that it expects to receive..
CI
2020Shenzhen Salubris Pharma Plans to Spin Off Unit for Listing
CI
2020Shenzhen Salubris Pharmaceuticals Co., Ltd. agreed to spin-off its biomedical engineeri..
CI
2020Shenzhen Salubris Pharmaceuticals Co., Ltd. Reports Earnings Results for the Nine Month..
CI
2020Shenzhen Salubris Pharmaceuticals Co., Ltd.'s Equity Buyback announced on October 8, 20..
CI
2020Shenzhen Salubris Pharmaceuticals Co., Ltd. announced that it expects to receive CNY 2 ..
CI
2020CLSA Asset Management Limited signed the share transfer agreement to acquire 5% stake i..
CI
2020CAP V MAURITIUS LIMITED MANAGED BY T : CG) agreed to acquire 5% stake in Shenzhen Salubris..
CI
2020Shenzhen Salubris Pharmaceuticals Co., Ltd. Reports Earnings Results for the Half Year ..
CI
2020Tranche Update on Shenzhen Salubris Pharmaceuticals Co., Ltd.'s Equity Buyback Plan ann..
CI
2020Shenzhen Salubris Pharmaceuticals Co., Ltd. Announces to Implement Final Cash Distribut..
CI
2020Shenzhen Salubris Pharmaceuticals Co., Ltd. Approves Final Cash Dividend for the Year 2..
CI
2020Shenzhen Salubris Pharmaceuticals Co., Ltd. completed the acquisition of remaining 15.7..
CI
2020Shenzhen Salubris Pharmaceuticals Co., Ltd. Announces Final Cash Dividend
CI
2020Shenzhen Salubris Pharmaceuticals Co., Ltd. intends to sign an equity transfer agreemen..
CI
2020Shenzhen Salubris Pharmaceuticals Co., Ltd. Reports Earnings Results for the Full Year ..
CI
2020Shenzhen Salubris Pharmaceuticals Co., Ltd. Reports Earnings Results for the First Quar..
CI
2020Tranche Update on Shenzhen Salubris Pharmaceuticals Co., Ltd.'s Equity Buyback Plan ann..
CI
2020Shenzhen Salubris Pharmaceuticals Co., Ltd. Announces Management Changes
CI
2020Tranche Update on Shenzhen Salubris Pharmaceuticals Co., Ltd.'s Equity Buyback Plan ann..
CI
2019Shenzhen Salubris Pharmaceuticals Co., Ltd. Reports Earnings Results for the Nine Month..
CI
2019Shenzhen Salubris Pharmaceuticals Co., Ltd. announces an Equity Buyback for CNY 500 mil..
CI
2019Shenzhen Salubris Pharmaceuticals Co., Ltd. authorizes a Buyback Plan.
CI
2019NORTAI International Ltd. announced that it expects to receive CNY 51.741026 million in..
CI
2019Shenzhen Salubris Pharmaceuticals Co., Ltd. Reports Earnings Results for the Half Year ..
CI
2019SHENZHEN SALUBRIS PHARMACEUTICALS CO : 002294) added to FTSE All-World Index
CI
2019Mercator MedSystems, Inc. announced that it has received $14.333502 million in funding ..
CI
2019Shenzhen Salubris Pharmaceuticals Co., Ltd. Reports Earnings Results for the First Quar..
CI
2019Shenzhen Salubris Pharmaceuticals Co., Ltd. Announces Final Distribution Plan for the Y..
CI
2019Shenzhen Salubris Pharmaceuticals Co., Ltd. Approves Final Cash Dividend for the Year 2..
CI
2019Shenzhen Salubris Pharmaceuticals Co., Ltd. Proposes 2018 Full Year Dividend
CI
2019Shenzhen Salubris Pharmaceuticals Co., Ltd. Reports Earnings Results for the Full Year ..
CI
2018Viracta and Salubris Announce Partnership to Bring Novel Treatment for Viral-Associated..
CI
2018NORTAI International Ltd. announced that it expects to receive HKD 78.6517 million in f..
CI
2018Shenzhen Salubris Pharmaceuticals Co., Ltd. agreed to acquire remaining 2% stake in hen..
CI
2018Genekey Biotech Co., Ltd. announced that it has received CNY 380 million in funding fro..
CI
2018Shenzhen Salubris Pharmaceuticals Co., Ltd. completed the acquisition of remaining 10% ..
CI
2018Shenzhen Salubris Pharmaceuticals Co., Ltd. intends to acquire Suzhou Huan Chen Medical..
CI
2018SHENZHEN SALUBRIS PHARMACEUTICALS : Announces Investment and In-Licensing Agreement With M..
BU
2018M.A. Med Alliance SA announced that it expects to receive $20 million in funding from S..
CI
2018Shenzhen Salubris Pharmaceuticals Co., Ltd. agreed to acquire remaining 10% stake in Ge..
CI
2018Genekey Biotech Co., Ltd. announced that it expects to receive CNY 380 million in fundi..
CI
2018Salubris Biotherapeutics Inc. announced that it expects to receive CNY 63.9 million in ..
CI
2018Mercator MedSystems, Inc. announced that it expects to receive $14.999997 million in fu..
CI
2018Salubris Announces Final Distribution Plan to Be Implemented (A Shares) for the Year 20..
CI
2018Salubris Approves Final Cash Dividend for the Year 2017
CI
2018NORTAI International Ltd. announced that it expects to receive CNY 150 million in fundi..
CI
2018Kingstronbio Co., Ltd. announced that it has received CNY 125 million in funding from S..
CI
2018Salubris Proposes Final Cash Dividend for the Year 2017
CI
2018Kingstronbio Co., Ltd. announced that it expects to receive CNY 125 million in funding ..
CI
2018Shenzhen Salubris Pharmaceuticals Co., Ltd. signed a share transfer agreement to acquir..
CI
2017Suzhou Genemen Biotech Co., Ltd. announced that it expects to receive CNY 550 million i..
CI
2017An unknown seller sold 1.2% stake in Shenzhen Salubris Pharmaceuticals Co., Ltd..
CI
2017Shenzhen Salubris Pharmaceuticals Co., Ltd. Approves Dividend for the Year 2016
CI
2017Shenzhen Salubris Pharmaceuticals Co., Ltd. Proposes Cash Dividend for 2016
CI
2016Shenzhen Salubris Pharmaceuticals Co., Ltd. cancelled the agreement to acquire 60% stak..
CI
2016Shenzhen Salubris Pharmaceuticals Co., Ltd., its management personnel and project manag..
CI
1  2Next
Upcoming event on SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.